TRADING UPDATES: Genflow patent progress; Accsys new debt facilities
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 0.15p on 06-11-2025 at 19:10:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.16p |
| Sell | 0.14p |
| Last Trade: | Sell 47,000.00 at 0.1493p |
| Day's Volume: | 1,078,522 |
| Last Close: | 0.15p |
| Open: | 0.15p |
| ISIN: | GB00BF3DT583 |
| Day's Range | 0.15p - 0.15p |
| 52wk Range: | 0.13p - 1.65p |
| Market Capitalisation: | £1.81m |
| VWAP: | 0.149621p |
| Shares in Issue: | 1.21b |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
polarean (POLX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 47,000 | 0.1493p | Ordinary |
14:04:46 - 06-Nov-25 |
| Sell* | 2,896 | 0.1493p | Ordinary |
13:55:55 - 06-Nov-25 |
| Buy* | 3,125 | 0.16p | SI Trade |
13:12:19 - 06-Nov-25 |
| Sell* | 11,835 | 0.1493p | Ordinary |
12:40:47 - 06-Nov-25 |
| Buy* | 3,125 | 0.16p | SI Trade |
12:23:46 - 06-Nov-25 |
| Sell* | 6,250 | 0.14p | SI Trade |
12:23:46 - 06-Nov-25 |
| Buy* | 943 | 0.16p | SI Trade |
12:23:46 - 06-Nov-25 |
| Sell* | 492,919 | 0.1493p | Ordinary |
11:00:16 - 06-Nov-25 |
| Sell* | 1,243 | 0.14p | SI Trade |
09:39:35 - 06-Nov-25 |
| Sell* | 1,200 | 0.14p | SI Trade |
09:39:35 - 06-Nov-25 |
polarean (POLX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Oct 2025 3:37 pm | RNS | Holding(s) in Company |
| 22nd Oct 2025 7:00 am | RNS | Strategic review and consideration of AIM listing |
| 6th Oct 2025 7:00 am | RNS | Ascend Imaging agreement expansion |
| 29th Sep 2025 7:00 am | RNS | University of Virginia Health Hospital agreement |
| 25th Sep 2025 12:14 pm | RNS | National Institutes of Health system order |
| 25th Sep 2025 7:00 am | RNS | Half-year Report |
| 16th Sep 2025 7:00 am | RNS | Notice of Results |
| 11th Sep 2025 4:36 pm | RNS | Holding(s) in Company |
| 12th Aug 2025 7:00 am | RNS | Submission of new Phase III study protocol to FDA |
| 24th Jul 2025 7:00 am | RNS | Block Listing Six Monthly Return |